美国国会考虑通过控制药房福利经理来降低药物成本的法案。 U.S. Congress considers bills to lower drug costs by reining in pharmacy-benefit managers.

美国国会正在考虑通过限制药房福利管理者的影响来降低处方药物费用的新法案。 The U.S. Congress is considering new bills to lower prescription drug costs by limiting the influence of pharmacy-benefit managers (PBMs). 这些实体在制造商和保险商之间谈判药品价格,并因成本膨胀而受到批评。 These entities negotiate drug prices between manufacturers and insurers, and have been criticized for inflating costs. NPR的Ayesha Rascoe讨论了旨在提高私营银行业透明度和问责制的立法工作,以便使药品价格更低廉。 NPR's Ayesha Rascoe discussed the legislative efforts aimed at increasing transparency and accountability in the PBM industry to make drugs more affordable.